Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001780088-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
17,041
Total Value
$459,824.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 17, 2026 | Sale | 3,577 | $32.74 | $117,108.83 | 50,071 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 17, 2026 | Sale | 2,587 | $33.38 | $86,342.16 | 47,484 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 18, 2026 | Sale | 6,100 | $31.28 | $190,831.18 | 41,384 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 18, 2026 | Sale | 483 | $31.79 | $15,353.99 | 40,901 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 18, 2026 | Sale | 103 | $32.85 | $3,383.55 | 40,798 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 19, 2026 | Exercise/Conversion | 1,365 | $2.19 | $2,989.35 | 42,163 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | Mar 19, 2026 | Sale | 1,461 | $29.99 | $43,815.39 | 40,702 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (Right to Buy) | Derivative | Mar 19, 2026 | Exercise/Conversion | 1,365 | $0.00 | $0.00 | 83,035 | Direct | โ | View Details |